Home
Alembic Pharmaceuticals Limited
Press Release Mar 06 2026
Business
Mar 6 2026
3 min read

Press Release Mar 06 2026

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 06, 2026, titled "Alembic Pharmaceuticals Reports First Prescription Sale of Pivya® (pivmecillinam) Following US Commercial Launch through Alembic Therapeutics LLC".

View Attachment

Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern